Could a sprinkle of antibiotic powder stop brain shunt infections in kids?

NCT ID NCT07547826

First seen Apr 23, 2026 · Last updated Jun 22, 2026 · Updated 13 times

Summary

This study tests whether applying vancomycin powder directly into the surgical wound during shunt placement can prevent infections in children with hydrocephalus. About 164 children will be randomly assigned to receive either standard care or standard care plus the powder. The goal is to see if this simple step reduces infection rates and is cost-effective.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYDROCEPHALUS IN INFANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Assiut University, Faculty of Medicine, Assiut University Hospitals, Department of Neurosurgery

    Asyut, Asyut Governorate, 71515, Egypt

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

vancomycin powder

What this could lead to

If it works, this could provide a simple, cheap way to prevent serious infections after shunt surgery in children.

What could go wrong

This is a single-center trial with 164 children, so results may not apply everywhere. Vancomycin powder might not reduce infections significantly, and there is a risk of antibiotic resistance or allergic reactions.

Conditions

The condition(s) this trial relates to.

Bacterial Infections and Mycoses hydrocephalus Postoperative Complications prosthesis-related infectious disease Surgical Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.